Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 3/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | RARB | P10826 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.40 |
| ▸ | SELE | P16581 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.40 |
| ▸ | RARG | P13631 | 1/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628638 | 0.99 | PLA2G4A (0.46) | PLA2G4ATRPV1RARBTHRBICAM1 | |
| SCHEMBL21628763 | 0.97 | PLA2G4A (0.41) | PLA2G4ATRPV1RARBLPAR1LPAR5 | |
| SCHEMBL21628586 | 0.92 | ALDH1A1 (0.41) | PLA2G4ATHRBALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21628886 | 0.88 | RARB (0.53) | PLA2G4ARARBRARARARGALDH1A1 | |
| SCHEMBL21628376 | 0.88 | SMN1; SMN2 (0.43) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21628429 | 0.87 | RARB (0.55) | PLA2G4ARARBRARARARGALDH1A1 | |
| SCHEMBL21628609 | 0.87 | ICAM1 (0.48) | PLA2G4ARARBTHRBICAM1SELE | |
| SCHEMBL21628454 | 0.86 | ICAM1 (0.49) | PLA2G4ARARBTHRBICAM1SELE | |
| SCHEMBL21628478 | 0.86 | MAPT (0.50) | RARBTHRBRARARARGSMN1; SMN2 | |
| SCHEMBL21628473 | 0.85 | MAPT (0.49) | PLA2G4ARARBICAM1SELERARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PLA2G4A 4624/4885TRPV1 577/4885RARB 1144/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PLA2G4A 4624/4885TRPV1 577/4885RARB 1144/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | PLA2G4A 4706/4885TRPV1 741/4885RARB 1064/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PLA2G4A 4624/4885TRPV1 577/4885RARB 1144/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | PLA2G4A 4521/4885TRPV1 1387/4885RARB 1531/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PLA2G4A 4624/4885TRPV1 577/4885RARB 1144/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PLA2G4A 4624/4885TRPV1 577/4885RARB 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.